Warning! GuruFocus detected
1 Severe warning sign
with TNFA.
Try a 7-Day Free Trial
to check it out.
What is a stock summary page? Click here for an overview.
Business Description
TNF Pharmaceuticals Inc
NAICS : 541713
SIC : 2833
ISIN : US62856X1028
Share Class Description:
TNFA: Ordinary SharesDescription
TNF Pharmaceuticals Inc is a clinical-stage pharmaceutical company committed to extending a healthy lifespan. The company is developing and commercializing two therapeutic platforms. MyMD-1 is a small molecule that regulates the immunometabolic system to treat autoimmune diseases, including multiple sclerosis, diabetes, rheumatoid arthritis, and inflammatory bowel disease. It is being developed to treat age-related illnesses such as frailty and sarcopenia. Supera-CBD is a synthetic derivative of CBD being developed to treat various conditions, including epilepsy, pain, and anxiety/depression, through its effects on the CB2 receptor, opioid receptors, and monoamine oxidase enzyme type B.
Financial Strength
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 591.22 | |||||
| Equity-to-Asset | 0.71 | |||||
| Interest Coverage | No Debt | |||||
| Piotroski F-Score | 4/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | -16.6 | |||||
| 3-Year EPS without NRI Growth Rate | -19.4 | |||||
| 3-Year FCF Growth Rate | -30.7 |
Momentum Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 43.17 | |||||
| 9-Day RSI | 44.72 | |||||
| 14-Day RSI | 41.1 | |||||
| 3-1 Month Momentum % | -67.82 | |||||
| 6-1 Month Momentum % | -75.29 | |||||
| 12-1 Month Momentum % | -82.43 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.72 | |||||
| Quick Ratio | 1.72 | |||||
| Cash Ratio | 1.52 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -17.7 | |||||
| Shareholder Yield % | 8.23 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| ROE % | -209.15 | |||||
| ROA % | -113.08 | |||||
| ROIC % | -86.25 | |||||
| 3-Year ROIIC % | -67.48 | |||||
| ROC (Joel Greenblatt) % | -26223.5 | |||||
| ROCE % | -73.73 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PB Ratio | 0.06 | |||||
| Price-to-Tangible-Book | 0.15 | |||||
| EV-to-EBIT | 0.8 | |||||
| EV-to-EBITDA | 0.8 | |||||
| EV-to-FCF | 0.9 | |||||
| Price-to-Net-Current-Asset-Value | 0.2 | |||||
| Price-to-Net-Cash | 0.25 | |||||
| Earnings Yield (Greenblatt) % | 125 | |||||
| FCF Yield % | -989.85 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:TNFA
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
TNF Pharmaceuticals Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | |||
| EPS (TTM) ($) | -13.84 | ||
| Beta | 2.37 | ||
| 3-Year Sharpe Ratio | -1 | ||
| 3-Year Sortino Ratio | -1.47 | ||
| Volatility % | 75.21 | ||
| 14-Day RSI | 41.1 | ||
| 14-Day ATR ($) | 0.052149 | ||
| 20-Day SMA ($) | 0.373883 | ||
| 12-1 Month Momentum % | -82.43 | ||
| 52-Week Range ($) | 0.325 - 3.5 | ||
| Shares Outstanding (Mil) | 2.76 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
TNF Pharmaceuticals Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
TNF Pharmaceuticals Inc Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| No Event Data | ||||
TNF Pharmaceuticals Inc Frequently Asked Questions
What is TNF Pharmaceuticals Inc(TNFA)'s stock price today?
The current price of TNFA is $0.37. The 52 week high of TNFA is $3.50 and 52 week low is $0.33.
When is next earnings date of TNF Pharmaceuticals Inc(TNFA)?
The next earnings date of TNF Pharmaceuticals Inc(TNFA) is 2025-05-15 Est..
Does TNF Pharmaceuticals Inc(TNFA) pay dividends? If so, how much?
TNF Pharmaceuticals Inc(TNFA) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers